PT827537E - Genes de regulação da cromatina - Google Patents

Genes de regulação da cromatina Download PDF

Info

Publication number
PT827537E
PT827537E PT96914165T PT96914165T PT827537E PT 827537 E PT827537 E PT 827537E PT 96914165 T PT96914165 T PT 96914165T PT 96914165 T PT96914165 T PT 96914165T PT 827537 E PT827537 E PT 827537E
Authority
PT
Portugal
Prior art keywords
chromatin
regulator genes
genes
deregulation
regulator
Prior art date
Application number
PT96914165T
Other languages
English (en)
Inventor
Thomas Jenuwein
Goetz Laible
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PT827537E publication Critical patent/PT827537E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT96914165T 1995-05-10 1996-05-02 Genes de regulação da cromatina PT827537E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19516776A DE19516776A1 (de) 1995-05-10 1995-05-10 Chromatin-Regulatorgene

Publications (1)

Publication Number Publication Date
PT827537E true PT827537E (pt) 2008-10-09

Family

ID=7761318

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96914165T PT827537E (pt) 1995-05-10 1996-05-02 Genes de regulação da cromatina

Country Status (11)

Country Link
US (2) US6689583B1 (pt)
EP (1) EP0827537B1 (pt)
JP (1) JP4295824B2 (pt)
AT (1) ATE404667T1 (pt)
CA (1) CA2220442C (pt)
DE (2) DE19516776A1 (pt)
DK (1) DK0827537T3 (pt)
ES (1) ES2313726T3 (pt)
MX (1) MX9708401A (pt)
PT (1) PT827537E (pt)
WO (1) WO1996035784A2 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19516776A1 (de) 1995-05-10 1996-11-14 Boehringer Ingelheim Int Chromatin-Regulatorgene
US6239327B1 (en) * 1998-04-16 2001-05-29 Cold Spring Harbor Laboratory Seed specific polycomb group gene and methods of use for same
DE60042883D1 (de) * 1999-03-11 2009-10-15 Arborgen Llc Zusammensetzungen und verfahren zur veränderung der gentranskription
US20020039776A1 (en) 2000-06-09 2002-04-04 Thomas Jenuwein Mammalian SUV39H2 proteins and isolated DNA molecules encoding them
US6555329B2 (en) * 2000-06-09 2003-04-29 Boehringer Ingelheim International Gmbh Method for identifying compounds altering higher-order chromatin-dependent chromosome stability
EP1325457A4 (en) * 2000-10-10 2007-10-24 Genencor Int LIBRARIES RICH IN INFORMATION
CA2451654A1 (en) 2001-06-22 2003-01-03 Ceres, Inc. Chimeric histone acetyltransferase polypeptides
US20040053848A1 (en) * 2001-08-23 2004-03-18 Allis C. David Antibodies specific for methylated lysines in histones
US20050106152A1 (en) * 2001-12-27 2005-05-19 Yuichi Hikichi Preventives/remedies for cancer
GB0228900D0 (en) * 2002-12-11 2003-01-15 Ml Lab Plc Cancer Immunotherapy
AU2003292737A1 (en) * 2002-12-24 2004-07-22 Takeda Pharmaceutical Company Limited Preventives/remedies for cancer
CN1914320A (zh) * 2003-12-03 2007-02-14 中外制药株式会社 利用哺乳类β肌动蛋白启动子的表达体系
JP2005170799A (ja) * 2003-12-08 2005-06-30 Univ Kurume ｚｅｓｔｅホモログ２のエンハンサーのＨＬＡ−Ａ２４結合ペプチド
US7563589B2 (en) * 2004-06-01 2009-07-21 The University Of North Carolina At Chapel Hill Reconstituted histone methyltransferase complex and methods of identifying modulators thereof
JP2009528050A (ja) * 2006-02-27 2009-08-06 イムジェン カンパニー リミテッド Ｂｍｉ−１を用いた星状細胞の神経幹細胞への脱分化
US8574832B2 (en) * 2010-02-03 2013-11-05 Massachusetts Institute Of Technology Methods for preparing sequencing libraries
US20130195843A1 (en) * 2010-06-23 2013-08-01 British Columbia Cancer Agency Branch Biomarkers for Non-Hodgkin Lymphomas and Uses Thereof
CA2841142C (en) 2010-06-23 2020-12-15 Ryan D. Morin Biomarkers for non-hodgkin lymphomas and uses thereof
US9175331B2 (en) * 2010-09-10 2015-11-03 Epizyme, Inc. Inhibitors of human EZH2, and methods of use thereof
KR102511807B1 (ko) 2010-09-10 2023-03-20 에피자임, 인코포레이티드 인간 ｅｚｈ2의 억제제 및 이의 사용 방법
EP2621942A4 (en) 2010-09-29 2015-01-21 Gen Hospital Corp MEANS FOR PROVIDING CONTROLS AND STANDARDS FOR IMMUNE PRECIPITATION ASSAYS
TW201733984A (zh) 2011-04-13 2017-10-01 雅酶股份有限公司 經取代之苯化合物
JO3438B1 (ar) 2011-04-13 2019-10-20 Epizyme Inc مركبات بنزين مستبدلة بأريل أو أريل غير متجانس
IN2014DN09068A (pt) 2012-04-13 2015-05-22 Epizyme Inc
AU2013331380B2 (en) 2012-10-15 2018-03-22 Epizyme, Inc. Substituted benzene compounds
CA2905070A1 (en) 2013-03-14 2014-09-25 Genentech, Inc. Methods of treating cancer and preventing cancer drug resistance
CN103215352B (zh) * 2013-03-29 2015-03-11 中国医学科学院血液病医院（血液学研究所） 一种检测setd2基因突变的试剂盒
CA2925889C (en) 2013-10-16 2020-09-29 Epizyme, Inc. Hydrochloride salt form for ezh2 inhibition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486623A (en) 1993-12-08 1996-01-23 Prototek, Inc. Cysteine protease inhibitors containing heterocyclic leaving groups
DE19516776A1 (de) 1995-05-10 1996-11-14 Boehringer Ingelheim Int Chromatin-Regulatorgene
WO1998027994A1 (en) 1996-12-20 1998-07-02 Board Of Regents, The University Of Texas System Proteins and compositions for modulating mitosis
US6004933A (en) 1997-04-25 1999-12-21 Cortech Inc. Cysteine protease inhibitors
US5972608A (en) 1997-08-27 1999-10-26 University Of Massachusetts Assays and reagents for chromatin remodeling enzymes and their modulators
EP1029547A1 (en) 1999-02-15 2000-08-23 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Pharmaceutically active compounds and method for identifying same
US6555329B2 (en) 2000-06-09 2003-04-29 Boehringer Ingelheim International Gmbh Method for identifying compounds altering higher-order chromatin-dependent chromosome stability
US20020039776A1 (en) 2000-06-09 2002-04-04 Thomas Jenuwein Mammalian SUV39H2 proteins and isolated DNA molecules encoding them
EP1227160A1 (en) 2001-01-19 2002-07-31 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Compounds modulating sister chromatid separation and method for identifying same
US20020164620A1 (en) 2001-01-19 2002-11-07 Boehringer Ingelheim International Gmbh Method for identifying compounds modulating sister chromatid separation
WO2003025117A2 (en) 2001-05-04 2003-03-27 University Of Florida Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor

Also Published As

Publication number Publication date
MX9708401A (es) 1998-02-28
WO1996035784A2 (de) 1996-11-14
DE19516776A1 (de) 1996-11-14
CA2220442A1 (en) 1996-11-14
US7252968B2 (en) 2007-08-07
US6689583B1 (en) 2004-02-10
EP0827537B1 (de) 2008-08-13
JP4295824B2 (ja) 2009-07-15
ATE404667T1 (de) 2008-08-15
WO1996035784A3 (de) 1996-12-27
EP0827537A2 (de) 1998-03-11
DE59611481D1 (en) 2008-09-25
CA2220442C (en) 2011-07-12
US20050089880A1 (en) 2005-04-28
JP2001505402A (ja) 2001-04-24
DK0827537T3 (da) 2008-12-01
ES2313726T3 (es) 2009-03-01

Similar Documents

Publication Publication Date Title
DE59611481D1 (en) Chromatin-regulatorgene
YU15299A (sh) Farmaceutski sastavi
NZ333399A (en) Cyclooxygenase-2 inhibitors (COX-2) for the prevention and treatment of tumors, cachexia and tumor-metastasis
AU2592600A (en) Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
AU6276194A (en) Use of monoterpenes, sesquiterpernes and diterpernes for the treatment of cancer
HUP9902068A3 (en) Methods and compositions for the diagnosis and treatment of cancer
MX9707570A (es) Utilizacion de agonistas de alta1l para el tratamiento de la incontinencia urinaria.
SI1187632T1 (sl) Zdravljenje z anti-ErbB2 protitelesi
CA2301032A1 (en) A method of preventing or treating estrogen-dependent diseases and disorders
GR970300016T1 (en) Lactobacillus strains of human origin, their compositions and uses thereof
MX9709146A (es) Compuestos novedosos, preparacion y uso de los mismos.
UA66793C2 (uk) Лептин як стримувач швидкого збільшення пухлини клітини
ES2184861T3 (es) Compuestos peptidicos inhibidores de la liberacion de la metaloproteinasa y del tnf y su utilizacion terapeutica.
GB9804886D0 (en) Therapeutic combination
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
GB9824437D0 (en) Gene therapy
WO1998030585A3 (en) Use of pea3 in tumor suppression
NZ320259A (en) Deodorizing preparations containing cationic biopolymers, aluminium hydrochlorate and esterase inhibitors
HK1043058A1 (zh) 異環磷酰胺芥子類似物及其用途
MX9700298A (es) Adenovirus que comprende un gen que codifica para una no sintasa.
MX9700624A (es) Azolidinonas de imidazopiridina.
IL139144A0 (en) Mycobacterial inhibitors
MX9601031A (es) Composicion farmaceutica para el tratamiento y prevencion del cancer de prostata.
AU5434899A (en) Cancer treatment
MX9804068A (es) Nuevos derivados de quinoxalindiona, su preparacion y empleo en medicamentos.